Literature DB >> 8242883

Evidence of increased nitric oxide production in patients with the sepsis syndrome.

T Evans1, A Carpenter, H Kinderman, J Cohen.   

Abstract

To investigate whether the hypotension of septic shock is due to an excess production of nitric oxide (NO), we have determined the serum levels of nitrate and nitrite (NO3/NO2), the stable end-products of NO, in 12 patients with the sepsis syndrome and marked hypotension. Compared to a mean NO3/NO2 level of 36.4 microM in controls (n = 7), the group of septic patients had a significantly elevated mean NO3/NO2 level of 124 microM (P < 0.01, Wilcoxon two-sample test). A lesser elevation was also seen in a group of postoperative patients (mean level 87.3 microM, n = 7), which was significantly elevated compared to controls (P < 0.01, Wilcoxon two-sample test), but was not significantly lower than the septic group (0.1 > P > 0.05, Wilcoxon two-sample test). These data suggest that NO may be responsible, at least in part, for the hypotension of septic shock.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8242883

Source DB:  PubMed          Journal:  Circ Shock        ISSN: 0092-6213


  21 in total

1.  In vivo measurement of nitric oxide production in porcine gut, liver and muscle during hyperdynamic endotoxaemia.

Authors:  Maaike J Bruins; Wouter H Lamers; Alfred J Meijer; Peter B Soeters; Nicolaas E P Deutz
Journal:  Br J Pharmacol       Date:  2002-12       Impact factor: 8.739

2.  Polymerized hemoglobin restores cardiovascular and kidney function in endotoxin-induced shock in the rat.

Authors:  M T Heneka; P A Löschmann; H Osswald
Journal:  J Clin Invest       Date:  1997-01-01       Impact factor: 14.808

3.  Reinforcement therapy using nitric oxide synthase inhibitors against endotoxin shock in dogs.

Authors:  Hiroyasu Suga; Takao Nakagawa; Yukihiro Soga; Yoshizumi Deguchi; Tadashi Suzuki; Norio Miyoshi; Yoshiaki Imamura; Masaru Fukuda
Journal:  Surg Today       Date:  2006       Impact factor: 2.549

4.  Increased production of nitric oxide in patients with hemorrhagic fever with renal syndrome--relation to arterial hypotension and tumor necrosis factor.

Authors:  M Linderholm; P H Groeneveld; A Tärnvik
Journal:  Infection       Date:  1996 Sep-Oct       Impact factor: 3.553

5.  Increases in pulmonary artery pressure and cardiac output due to the inhibition of nitric oxide synthesis during operative stress.

Authors:  K Sasajima; M Onda; M Miyashita; K Ohkawa; T Matsutani; Y Akiya; S Takeda; R Ogawa; Y Kurashima; H Esumi
Journal:  Surg Today       Date:  1995       Impact factor: 2.549

Review 6.  Pharmacologic management of perioperative pulmonary hypertension.

Authors:  Julie W Cheng; Adriano R Tonelli; Gosta Pettersson; Richard A Krasuski
Journal:  J Cardiovasc Pharmacol       Date:  2014-04       Impact factor: 3.105

7.  Detection and comparison of nitric oxide in clinically healthy horses and those with naturally acquired strangulating large colon volvulus.

Authors:  Mustajab H Mirza; Thomas L Seahorn; Julian L Oliver; Giselle Hosgood; Rustin M Moore
Journal:  Can J Vet Res       Date:  2005-04       Impact factor: 1.310

8.  Activation of nuclear factor kappaB and induction of inducible nitric oxide synthase by Ureaplasma urealyticum in macrophages.

Authors:  Y H Li; Z Q Yan; J S Jensen; K Tullus; A Brauner
Journal:  Infect Immun       Date:  2000-12       Impact factor: 3.441

9.  Artery-to-vein differences in nitric oxide metabolites are diminished in sepsis.

Authors:  Mary Anne M Morgan; Lauren M Frasier; Judith C Stewart; Cynthia M Mack; Michael S Gough; Brian T Graves; Michael J Apostolakos; Kathleen P Doolin; Denise C Darling; Mark W Frampton; Anthony P Pietropaoli
Journal:  Crit Care Med       Date:  2010-04       Impact factor: 7.598

Review 10.  Selective iNOS inhibition for the treatment of sepsis-induced acute kidney injury.

Authors:  Suzanne Heemskerk; Rosalinde Masereeuw; Frans G M Russel; Peter Pickkers
Journal:  Nat Rev Nephrol       Date:  2009-09-29       Impact factor: 28.314

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.